Adicet Bio, Inc.
Adicet Bio, Inc. (ACET) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ACET · as of Jun 9, 2026
Activity summary
Buy transactions
5
P-Purchase only
Sell transactions
4
12 Months
Buy/Sell ratio
1.25
Buy/Sell (by trades)
Overall sentiment
Adicet Bio, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
ACET insider buying and selling by quarter
ACET insider selling · ACET insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · ACET ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ACET executive sell shares · ACET board member insider trading · ACET insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 27, 2026 | RA CAPITAL MANAGEMENT, L.P. 10 percent owner | Other | 250,000 | $25 | Form 4 |
| Feb 20, 2026 | RA CAPITAL MANAGEMENT, L.P. 10 percent owner | Purchase | 74,751 | $543K | Form 4 |
| Feb 19, 2026 | RA CAPITAL MANAGEMENT, L.P. 10 percent owner | Purchase | 74,268 | $535K | Form 4 |
| Feb 18, 2026 | RA CAPITAL MANAGEMENT, L.P. 10 percent owner | Purchase | 74,577 | $525K | Form 4 |
| Apr 7, 2026 | ORBIMED ADVISORS LLC 10 percent owner | Sale | 29,319 | $191K | Form 4 |
| Apr 7, 2026 | ORBIMED ADVISORS LLC 10 percent owner | Sale | 2,400 | $15K | Form 4 |
| Apr 8, 2026 | ORBIMED ADVISORS LLC 10 percent owner | Sale | 32,523 | $205K | Form 4 |
| Apr 8, 2026 | ORBIMED ADVISORS LLC 10 percent owner | Sale | 40,416 | $264K | Form 4 |
| Jan 24, 2026 | Aftab Blake Chief Scientific Officer | Other | 535 | $5K | Form 4 |
| Jan 24, 2026 | Healey Don CTO | Other | 535 | $5K | Form 4 |
| Jan 24, 2026 | Schor Chen President & CEO · Director | Other | 1,755 | $15K | Form 4 |
| Jan 24, 2026 | Harvey Brian Nicholas CFO | Other | 546 | $5K | Form 4 |
| Oct 8, 2025 | ORBIMED ADVISORS LLC 10 percent owner | Purchase | 1,500,000 | $1.50M⚡ | Form 4 |
| Oct 8, 2025 | ORBIMED ADVISORS LLC 10 percent owner | Purchase | 3,500,000 | $3.50M⚡ | Form 4 |
| Jun 11, 2025 | Klickstein Lloyd Director | Award | 5,900 | — | Form 4 |
| Jun 11, 2025 | Chodakewitz Jeffrey Director | Award | 5,900 | — | Form 4 |
| Jun 11, 2025 | DUBIN STEVE Director | Award | 5,900 | — | Form 4 |
| Jun 11, 2025 | Peng Katie Director | Award | 5,900 | — | Form 4 |
| Jun 11, 2025 | Sinclair Andrew Director | Award | 5,900 | — | Form 4 |
| Jan 24, 2025 | Schor Chen President & CEO · Director | Other | 28,101 | $26K | Form 4 |
| Jan 24, 2025 | Healey Don CTO | Other | 8,560 | $8K | Form 4 |
| Jan 24, 2025 | Aftab Blake Chief Scientific Officer | Other | 6,270 | $6K | Form 4 |
| Jan 24, 2025 | Harvey Brian Nicholas CFO | Other | 8,752 | $8K | Form 4 |
| Jun 5, 2024 | GORDON CARL L Director | Award | 5,900 | — | Form 4 |
| Jun 5, 2024 | Chodakewitz Jeffrey Director | Award | 5,900 | — | Form 4 |
RA CAPITAL MANAGEMENT, L.P.
10 percent owner
Date
Apr 27
Shares
250,000
Price
$0.00
Value
$25
RA CAPITAL MANAGEMENT, L.P.
10 percent owner
Date
Feb 20
Shares
74,751
Price
$7.27
Value
$543K
RA CAPITAL MANAGEMENT, L.P.
10 percent owner
Date
Feb 19
Shares
74,268
Price
$7.21
Value
$535K
RA CAPITAL MANAGEMENT, L.P.
10 percent owner
Date
Feb 18
Shares
74,577
Price
$7.04
Value
$525K
ORBIMED ADVISORS LLC
10 percent owner
Date
Apr 7
Shares
29,319
Price
$6.53
Value
$191K
ORBIMED ADVISORS LLC
10 percent owner
Date
Apr 7
Shares
2,400
Price
$6.38
Value
$15K
ORBIMED ADVISORS LLC
10 percent owner
Date
Apr 8
Shares
32,523
Price
$6.29
Value
$205K
ORBIMED ADVISORS LLC
10 percent owner
Date
Apr 8
Shares
40,416
Price
$6.52
Value
$264K
Schor Chen
President & CEO · Director
Date
Jan 24
Shares
1,755
Price
$8.44
Value
$15K
ORBIMED ADVISORS LLC
10 percent owner
Date
Oct 8
Shares
1,500,000
Price
$1.00
Value
$1.50M ⚡
ORBIMED ADVISORS LLC
10 percent owner
Date
Oct 8
Shares
3,500,000
Price
$1.00
Value
$3.50M ⚡
Schor Chen
President & CEO · Director
Date
Jan 24
Shares
28,101
Price
$0.92
Value
$26K
Aftab Blake
Chief Scientific Officer
Date
Jan 24
Shares
6,270
Price
$0.92
Value
$6K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ACET insider trading
ACET insider trades
Adicet Bio, Inc. (ACET) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including ORBIMED ADVISORS LLC (10 percent owner), RA CAPITAL MANAGEMENT, L.P. (10 percent owner), Aftab Blake (Chief Scientific Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. ACET insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Adicet Bio, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ACET insider trading · 5 questionsThe insiders of Adicet Bio, Inc. (ACET) include executives and directors such as ORBIMED ADVISORS LLC (10 percent owner), RA CAPITAL MANAGEMENT, L.P. (10 percent owner), Aftab Blake (Chief Scientific Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026